200+ total transactions representing $4B+ in aggregate value — 10 tracked below spanning 2013–2026 · 6 industries
Buy-side and restructuring advisory for a cannabis company facing operational and financial challenges.
Buy-side representation for a healthtech and healthcare services company acquisition.
Engaged to assist with balance sheet restructuring and working capital facilitation for RedHawk's expansion of branded generic licenses.
Provided strategic and financial advisory to a cybersecurity and technology company on corporate positioning and strategic alternatives.